Ipenoksazon

С Википедије, слободне енциклопедије

Ipenoksazon
(4S,5R)-3-[3-(azepan-1-il)propil]-4-(2-metilpropil)-5-fenil-1,3-oksazolidin-2-on
Nazivi
IUPAC naziv
(4S,5R)-3-[3-(azepan-1-il)propil]-4-(2-metilpropil)-5-fenil-1,3-oksazolidin-2-on
Drugi nazivi
  • 104454-71-9
  • NC-1200
  • 839F26EVAQ
  • CHEMBL2104917
Identifikacija
3D model (Jmol)
  • CC(C)CC1C(OC(=O)N1CCCN2CCCCCC2)C3=CC=CC=C3
Svojstva
C22H34N2O2
Molarna masa 358,53 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

Ipenoksazon je antagonist NMDA receptora.[3]

Reference[уреди | уреди извор]

  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  уреди
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. стр. 415—478.